American Thoracic Society Announces that Boehringer Ingelheim is the First Donor of its COVID‐19 Crisis Fund
RIDGEFIELD, CT -- As part of Boehringer Ingelheim’s commitment to fighting the COVID-19 pandemic and long-standing partnership with the pulmonology community, the company is donating $500,000 to the American Thoracic Society (ATS) COVID-19 Crisis Fund.